Article
Massively parallel DNA sequencing successfully identifies new causative mutations in deafness genes in patients with cochlear implantation and EAS.
PloS one - 1 Jan 2013
Miyagawa Maiko, Nishio Shin-ya, Ikeda Takuo, Fukushima Kunihiro, Usami Shin-ichi
Abstract excerpt
Genetic factors, the most common etiology in severe to profound hearing loss, are one of the key determinants of Cochlear Implantation (CI) and Electric Acoustic Stimulation (EAS) outcomes. Satisfactory auditory performance after receiving a CI/EAS in patients with certain deafness gene mutations indicates that genetic testing would be helpful in predicting CI/EAS outcomes and deciding treatment choices. However,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
